Market Update: STI ends three-day gains

The Straits Times Index slid back into negative territory on Wednesday, ending the day's trading down by 22.08 points, or 0.76%, at 2,869.55.

Investors took a breather after three-days of gains as pharmaceutical companies announced that their testing phase of their COVID-19 vaccines were nearing an end.

Top stock losers for the day were ComfortDelGro with 0.08 points to 4.52%, SATS with 0.18 to 4.11%, and Keppel DC REIT with 0.06 to 2.07%.

Singapore’s Health Ministry has recorded seven new coronavirus cases, all coming from different countries in Asia, building up the total cases to 58,190. However, there were no reported community cases for the 15th day in a row.

This has been the longest stretch without a community case since the very first infection in the country last January 23.

Meanwhile, London's blue-chip index slumped by 0.64% dragged down by major banks and individual healthcare stocks.

The FTSE Mid Cap also closed down by 1.1% for the day, with industrials and consumer sectors pulling the index. 

Join Singapore Business Review community
Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.